Explosion of New Medications to Combat Obesity

Our “toolbox” of medication for obesity as been empty since several previously FDA approved drugs were removed from the market. Sibutramine was removed becasue of controversial information suggesting Sibutramine caused heart attacks. Nevertheless, we now have two new agents, Qsymia and Locaserin, approved as well as Contrave (yet to be approved) which are expanding options to treat obesity. Full discusssion to follow.